跳至主要内容
临床试验/NCT01099956
NCT01099956已完成不适用

Low Grade Inflammation in Type 1 Diabetes Children

University Hospital, Bordeaux1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2010年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80
试验地点
1
主要终点
Increase of Interleukine 6 in group DTI versus control group

研究概览

简要总结

The study propose to measure the inflammation level in type 1 diabetes children with the cytokine analysis compared to non diabetic children of the same sibling and to healthy children.

详细描述

The increase of type 1 diabetes incidence, particularly in young children leads to conduce new diagnostic and therapeutic strategies, notably for associated chronic morbidity.Measurement of chronic inflammation, with modification of the balance between pro-inflammatory cytokines and anti-inflammatory cytokines, could lead to detect patients with high risk to diabetes chronic morbidity.

After parental consent, blood sampling will be carried out by micromethod for cytokine (500 µl) and CRPhs dosages and glycemia (100 µl) and glycated hemoglobin (1 µl). Urine will be collected (50 ml) in the morning for further researches.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
2 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Type 1 diabetes children group :
  • Children aged 2 to 17 years
  • Type 1 diabetes children
  • Controlled group :
  • Children aged 2 to 17 years
  • Brother or sister of type 1 diabetes children

排除标准

  • Per os or inhaled corticoid in the previous month of inclusion
  • Acute infectious disease in the previous week of inclusion
  • Other chronic disease than diabetes type1

结局指标

主要结局

Increase of Interleukine 6 in group DTI versus control group

时间窗: Once at inclusion

次要结局

  • Increase of others cytokines (IL1-beta, l'IL-4, l'IL-10 and TNF alpha) and increase of High sensitivity CRP in group DTI versus control group(Once at inclusion)

研究者

发起方
University Hospital, Bordeaux
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验